Cited by 218Renin-Angiotensin System StudiesHormonal Regulation and HypertensionEicosanoids and Hypertension Pharmacology

Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells

Open access
Mazak, Istvan, Fiebeler, Anette, Muller, Dominik N., Park, Joon-Keun, Shagdarsuren, Erdenechimeg, Lindschau, Carsten, Dechend, Ralf, Viedt, Christiane +3 more·2004·Circulation

Abstract

Background— In a double-transgenic human renin and human angiotensinogen rat model, we found that mineralocorticoid receptor (MR) blockade ameliorated angiotensin II (Ang II)–induced renal and cardiac damage. How Ang II and aldosterone (Ald) might interact is ill defined. Methods and Results— We investigated the effects of Ang II (10 −7 mol/L) and Ald (10 −7 mol/L) on extracellular signal–regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) signaling in vascular smooth muscle cells (VSMCs) with Western blotting and confocal microscopy. Ang II induced ERK 1/2 and JNK phosphorylation by 2 minutes. Ald achieved the same at 10 minutes. Ang II+Ald had a potentiating effect by 2 minutes. Two oxygen radical scavengers and the epidermal growth factor receptor (EGFR) antagonist AG1478 reduced Ang II–, Ald-, and combination-induced ERK1/2 phosphorylation. Preincubating the cells with the MR blocker spironolactone (10 −6 mol/L) abolished Ang II–induced ROS generation, EGFR transactivation, and ERK1/2 phosphorylation. Conclusions— Ald potentiates Ang II–induced ERK-1/2 and JNK phosphorylation. Oxygen radicals, the MR, and the EGFR play a role in early signaling induced by Ang II and Ald in VSMCs. These in vitro data may help explain the effects of MR blockade on Ang II–induced end-organ damage in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000131860.80444.ab

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Aldosterone enhances Ang II-stimulated ERK1/2 phosphorylation in vascular smooth muscle cells.

    “Aldosterone enhances Ang II-stimulated ERK1/2 phosphorylation in vascular smooth muscle cells.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [104]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 218

Research works printed but not linked: 1

  1. Carpenter G. The EGF receptor: a nexus for trafficking and signaling. Bioessays. 2000;22:697-707.

Authors
Mazak, I., Fiebeler, A., Muller, D. N., Park, J.-K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H., & Luft, F. C.
Affiliations
  • From Medical Faculty of the Charité, Franz Volhard Clinic, HELIOS Klinikum-Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany (I.M., A.F., D.N.M., E.S., R.D., B.P., F.C.L.); the Department of Internal Medicine and Nephrology, Hannover University Medical School, Hannover, Germany (J.-K.P., C.L., H.H.); and the Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany (C.V.).
  • Max Delbrück Center (DE)
Venue
Circulation
Published
2004-06-08
Volume
109
Issue
22
Pages
2792-2800
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2126174661
Cited by
218
References
39
Citations by year
2025: 2 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 8 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 11 · 2013: 9 · 2012: 11
FWCI
17.14
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • German Medical Science (German Research Foundation) (publishedVersion, cc-by-nc-nd)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
aldosterone, angiotensin II, vascular smooth muscle cells, mineralocorticoid receptor, ERK1/2 phosphorylation, JNK phosphorylation, reactive oxygen species, epidermal growth factor receptor transactivation, spironolactone, renin-angiotensin system
MeSH terms
Aldosterone, Mineralocorticoid Receptor Antagonists, Angiotensin II, Animals, Cells, Cultured, Male, Muscle, Smooth, Vascular, Phosphorylation, Spironolactone, Signal Transduction, Rats, Sprague-Dawley, Reactive Oxygen Species, Animals, Genetically Modified, JNK Mitogen-Activated Protein Kinases, Extracellular Signal-Regulated MAP Kinases, Rats, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review